SPOTLIGHT -
The new technology has the potential to be safer with the delivery of micropulses of BSS, which results in littleor no increase in temperature or vibration inside the eye.
Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results
Commercial real estate and your practice, part two with Colin Carr
UT Southwestern ophthalmologist shares techniques for cataract surgery complications
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
ARVO announces recipients of 2023 Pfizer Ophthalmics Carl Camras Translational Research Award
Expanding gene therapy for Usher Syndrome Type 2A